This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Dry Eye Syndrome Treatment Market

Market Insights on Dry Eye Syndrome Treatment covering sales outlook, demand forecast & up-to-date key trends

Dry Eye Syndrome Treatment Market by Product Type, Prescription, Distribution Channel &Region -Forecast for 2022-2031

Dry Eye Syndrome Treatment Market Overview (2022-2031)

[314 Pages Report] The global dry eye syndrome treatment market size is estimated to reach US$ 4.80 Bn in 2022 and is projected to grow at a healthy CAGR of 7.0% between 2022 and 2032, surpassing a valuation of US$ 8.84 Bn by the end of 2031.

Rising prevalence of dry eye syndrome, along with increasing demand for dry eye treatment for relieving various symptoms is a major factor boosting the growth of dry eye syndrome treatment market.

Dry eye disease (DED) has become a public health concern causing ocular discomfort, fatigue and visual disturbance that interferes with quality of life. It is one of the most common and uncomfortable ocular surface diseases (OSDs).

It occurs when tears are not able to provide adequate moisture/lubrication or there is low production of tears. Presence of this condition can lead to numerous symptoms ranging from redness of the eyes, burning sensation, and inflammation to itching and blurry vision.

The rapid rise in dry eye disease cases coupled with increasing adoption of various treatments like dry eye treatment drops and artificial tears for relieving multiple symptoms will create opportunities for growth in dry eye syndrome treatment market and eyecare products market during the forecast period.

In addition to this, rising popularity of excimer and femtosecond ophthalmic lasers for treating dry eye syndrome will auger well for the market in the forthcoming years.

Market Outlook:

Data Points

Market Insights

Dry Eye Syndrome Treatment Market Value 2021

US$ 4.52 Bn

Dry Eye Syndrome Treatment Market Value 2022

US$ 4.80 Bn

Dry Eye Syndrome Treatment Market Value 2031

US$ 8.84 Bn

Dry Eye Syndrome Treatment Market Forecast CAGR 2022-2031

7.0%

Market Share of Top 5 Countries

53.4%

Key Players

Allergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Bausch Health Companies, Inc. Akron, Inc., Johnson & Johnson, Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC, Medicom Healthcare Ltd, FDC Limited., Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited.

In recent years there has been a sharp rise in various eye diseases due to increasing usage of electronic gadgets such as cell phones, tablets and laptops. This has generated immense demand for dry eye treatments and the trend is likely to escalate during the forecast period.

Similarly, increase in the number of eye care centers worldwide and rising penetration of OTC eyedrop market across both developed and developing regions will boost market growth during the assessment period.

In 2021, the dry eye syndrome treatment market accounted for around 12% of the US$ 36.0 Bn ophthalmology drugs market in 2021. Rising demand for dry eye syndrome treatments along with rapid expansion of ophthalmic eye drops market worldwide will continue to augment market growth in upcoming years.

Customize this Report

Let us know your requirement to get
100% FREE customization

2016-2021 Market Demand Outlook For Dry Eye Syndrome Treatment Compared To 2022-2031 Forecast

The global sales of dry eye syndrome treatment is expected to rise at a robust CAGR of 7% between 2022 and 2032 in comparison to 6.2% CAGR registered from 2016 and 2021. Increasing incidence of dry eye syndrome worldwide, rise in product development and innovation, surge in number of LASIK surgeries, and rapid expansion of eyedrop market are some of the key factors driving the growth in dry eye syndrome treatment market.

Dry eye syndrome treatment includes a wide range of therapeutics that are being utilized to treat dry eye syndrome. Adoption of these treatments significantly reduces various symptoms associated with dry eye syndrome and thus enable patients to lead a quality life.

Dry Eye Syndrome Treatment Market Download Report Brochure

Growing awareness among individuals about dry eye syndrome and its symptoms is expected to boost the sales of dry eye syndrome treatment during the forecast period. Furthermore, exponential growth of eye infections treatment market across developing regions will make a conducive environment for the manufacturers of dry eye syndrome treatments in future.

Similarly, expansion of dry eye remedies market size across developing regions along with surging adoption of dry eye treatment drops by patients for relieving multiple symptoms will generate lucrative opportunities for the manufacturers of dry eye syndrome treatment.

Which Factors Are Restraining The Growth In Dry Eye Syndrome Treatment Market?

Despite a positive growth trajectory, the global dry eye syndrome treatment market is facing various challenges that are likely to pose a threat to its growth during the forecast period. Some of these factors are lack of awareness about dry eye disease and poor availability of certain products across emerging economies.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-Wise Insights

What Makes the U.S. an Attractive Market for Dry Eye Syndrome Treatment?

“Booming Eyecare Products Market and Rising Investments in Research and Development Driving Growth in the U.S. Market”

The U.S. is estimated to account for over 80.6% of the North America dry eye syndrome treatment market in 2022. Rising prevalence of dry eye syndrome, presence of leading pharmaceutical manufacturers, and rapid expansion of eyecare products market and vision care market are some of the factors driving demand in the U.S. market.

Similarly, increasing research and development activities for novel treatments, rising consumer awareness about the prevailing dry eye disease treatment market trends, and growing popularity of dry eye treatment drops are expected to aid market growth in the region during the forecast period.

Why is Germany Considered a Lucrative Market for Dry Eye Syndrome Treatment?

“Heavy Presence of Leading Market Players Favoring Market Growth in Germany”

Germany is expected to dominate the Europe dry eye syndrome treatment market with around 17.2% value share in 2022. Large presence of pharmaceutical companies, rapid growth of OTC eyedrop market, and growing aging populations is driving the demand in the Germany market.

What are the Factors Fueling the Demand for Dry Eye Syndrome Treatment in China?

"Rising Geriatric Population and Surge in Dry Eye Disease Cases Fueling Demand in China”

The dry eye syndrome treatment market in China is projected to grow at 9.5% CAGR throughout the forecast period. Amid rising prevalence of keratoconjunctivitis sicca (KS), there is a rapid surge in research & development activities to develop new drugs for effective treatment of the disease.

Similarly, flourishing eyedrop market, rising geriatric population, availability of various dry eye treatment drops at lower costs, and rapid expansion of dry eye remedies market size are expected to create lucrative opportunities for the manufacturers of dry eye syndrome treatments across China during the forecast period.

Category-Wise Insights

Which is the Top Selling Product for the Treatment of Dry Eye Syndrome?

“Demand for Artificial Tears to Continue Gaining Traction”

By product, artificial tears segment accounted for the maximum share of 60.8% in 2021 and is expected to grow at a healthy CAGR of 7.1% during the forecast period.

Factors such as high prevalence of dry eye disease, increasing screen time, aging population, rising demand for dry eye treatment, and highly effective nature of artificial tears in reducing various symptoms of dry eye syndrome are triggering growth in this segment.

Which Prescription Category Leads the Global Dry Eye Syndrome Treatment Market?

“Rx Segment to Lead the Global Dry Eye Syndrome Treatment Market”

In terms of prescription, Rx (prescription) medicine segment accounted for 71.4% of the total market share in 2021 and is forecast to grow at a significant pace during the assessment period. Availability of novel products with improved mechanism of action, making it preferred choice among ophthalmologist is one of the primary factors positively driving the sales of the prescription drugs.

Which Distribution Segment Accounts for the Largest Revenue Generation?

“Hospital Pharmacies and Retail Pharmacies to Remain Attractive Destinations for Dry Eye Syndrome Treatment”

By distribution channel, hospital pharmacies and retail pharmacies together accounted for more than 80.0% of the dry eye syndrome treatment market in 2021 and the trend is expected to continue throughout the forecast period (2022-2031). Hospital pharmacies are given preference as most of the medications are prescribed after thorough eye examination by an ophthalmologist.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

llergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Bausch Health Companies, Inc. Akron, Inc., and Johnson & Johnson, Inc. are some of the leading players operating in the market.

Key players in dry eye syndrome treatment market are actively seeking to strengthen their position through new product launches, approvals, and agreements. They are vigorously investing in research and development activities to introduce novel products with effective and long-lasting features.

For instance:

  • In October 2021, the U.S. Food and Drug Administration (FDA) approved Tyrvaya nasal spray for dry eye. The spray simulates tear, oil and mucin production and thus eliminates undesirable ocular stinging and burning sensations.
  • In October 2019, Sun Pharmaceutical Industries Ltd, announced that one of its wholly owned subsidiaries has commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. With U.S.

Scope Of The Report

Understand the prevailing trends and emerging opportunities in the dry eye syndrome treatment market with latest report from the leading research firm Future Market Insights. Know in detail about the major forces behind the expansion of dry eye syndrome treatment market.

Besides underscoring the impact of government initiatives to tackle the rising burden of dry eye syndrome, FMI’s report highlights the correlation between ophthalmic eye drops market and dry eye syndrome treatment market.

It provides solutions to queries like how will the development of novel therapeutics affect growth of dry eye syndrome treatment market? Why is North America dominating the global dry eye syndrome treatment market? and which factors are making Asia Pacific a lucrative market for dry eye syndrome treatment? Detailed information on this is compiled in the dry eye syndrome treatment market analysis, which is interspersed with relevant statistics and graphs.

The Dry Eye Syndrome Treatment market analysis includes:

  • A 9-year realistic dry eye syndrome treatment sales forecast slicing forecast across multiple verticals
  • Demand and supply trend analysis across 25 countries for dry eye treatment drops
  • Impact of novel product development and launches on dry eye syndrome treatment market
  • Systematic analysis of regional pockets and leading segments of dry eye syndrome treatment in detail
  • Illustrative representation of statistical data showcasing sales trends across each year over the assessment period
  • Strategies adopted by leading dry eye syndrome treatment market players to stay on top of the ladder
  • Cascading effect of the dry eye remedies market growth on dry eye syndrome treatment sales
  • Dry eye disease treatment market trends and their influence on sales prospects of dry eyes treatment
  • Most effective go-to-market strategy for dry eye syndrome treatment market growth
  • Governing factors including consumer preference, trends driving sales of OTC eyedrops and their impact on sales of dry eye syndrome treatment

Attribute

Details

Forecast Period

2022-2031

Historic Data Available for

2016-2021

Market Analysis

US$ Million for Value

Report Coverage

Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Key Segments Covered

  • Product
  • Prescription
  • Distribution Channel
  • Region

Key regions covered

North America

  • US
  • Canada
  • Rest of North America

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Western Europe

  • Germany
  • U.K.
  • France
  • Rest of Western Europe

Eastern Europe

  • Russia
  • Spain
  • Rest of Eastern Europe

South Asia Pacific

  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific

Middle East & Africa

  • GCC Countries
  • Turkey
  • Israel
  • Rest of MEA

Rest of the World

  • Oceania
  • Africa
  • South America

Distribution Channel

  • Hospital Pharmacies
  • Eye Health Clinics
  • Retail Pharmacies
  • Online Pharmacies

Key companies profiled

Allergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Bausch Health Companies, Inc., Akron, Inc., Johnson & Johnson, Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC, Medicom Healthcare Ltd, FDC Limited., Lupin Limited, Jamjoom Pharmaceuticals Co., Sentiss Pharma Private limited.

Customization & pricing

Available upon request

Dry Eye Syndrome Treatment Market By Category

By Product:

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
    • Removable
    • Dissolvable
  • Oral Omega Supplements
  • Others

By Prescription:

  • Rx
  • OTC
  • Medical Device

By Distribution Channel:

  • Hospital Pharmacies
  • Eye Health Clinics
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global dry eye syndrome treatment market is set to grow at 7.0% CAGR throughout the forecast period.

North America currently holds the largest market share of 37.6% in the dry eye syndrome treatment market.

Rise in number of research & development activities to develop effective treatment for dry eye syndrome and OTC availability of the DES drugs are some of the key trends witnessed in this market place.

The dry eye syndrome treatment market in Japan is expected to grow at 6.1% CAGR during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Method Innovation / Development Trends

4. Key Success Factors

    4.1. Dry Eye Syndrome Epidemiology, By Country, 2016-2031

        4.1.1. Prevalence of dry eye disease 

        4.1.2. Potential patient number of dry eye disease

        4.1.3. Percentage of severity, mild, modulate, and severe

        4.1.4. Patients number under treatment

        4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient

    4.2. Regulatory Scenario

    4.3. New Product Launches

    4.4. Reimbursement Scenario

    4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries

    4.6. Dry Eye Syndrome – Patient Treatment Journey

5. Market Background

    5.1. Macro-Economic Factors 

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increase in Geriatric Population 

        5.2.2. Increasing Prevalence of Dry Eye Syndrome 

        5.2.3. Limited Awareness About Dry Eye Syndrome 

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Trends

        5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product 

        6.4.2. Revenue By Distribution Channel 

        6.4.3. Revenue By Prescription

        6.4.4. Revenue By Country

7. Global Dry Eye Syndrome Market Demand (In Volume Units) Analysis 2016–2021 and Forecast, 2022-2031

    7.1. Historical Market (Volume) Analysis, 2016–2021

    7.2. Current and Future Market (Volume) Projections, 2022-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Dry Eye Syndrome Market- Pricing Analysis

    8.1. Regional Pricing Analysis, By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Average Pricing Analysis Benchmark

9. Global Dry Eye Syndrome Market Value (US$ Mn) Analysis 2016-2021 and Forecast, 2022-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031, By Product 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Product, 2016-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2031

        10.3.1. Cyclosporin

        10.3.2. Topical Corticosteroids

        10.3.3. Artificial Tears

        10.3.4. Punctal plugs

            10.3.4.1. Removable 

            10.3.4.2. Dissolvable

        10.3.5. Omega Supplements

    10.4. Others Market Attractiveness Analysis, By Product

11. Global Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031, By Prescription 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Prescription, 2016-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Prescription, 2022-2031

        11.3.1. Rx

        11.3.2. OTC

        11.3.3. Medical Device

    11.4. Others Market Attractiveness Analysis, By Prescription

12. Global Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By Distribution Channel, 2016-2021

    12.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2022-2031

        12.3.1. Hospital Pharmacies

        12.3.2. Eye Health Clinics

        12.3.3. Retail Pharmacies

        12.3.4. Online Pharmacies

    12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2016 - 2021

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis, By Region

14. North America Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022-2031

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Prescription

        14.3.4. By Distribution Channel 

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Latin America Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016 - 2021

    15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022-2031

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Prescription

        15.3.4. By Distribution Channel 

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Europe Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2022-2031

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. Poland

            16.3.1.8. Rest of Europe

        16.3.2. By Product

        16.3.3. By Prescription

        16.3.4. By Distribution Channel 

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. South Asia Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016-2021

    17.3. Current and Future Market Size (US$ Mn) Analysis, By Market Taxonomy 2022-2031

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Vietnam

            17.3.1.6. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Prescription

        17.3.4. By Distribution Channel 

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. East Asia Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016-2021

    18.3. Current and Future Market Size (US$ Mn) Analysis, By Market Taxonomy, 2022-2031

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product

        18.3.3. By Prescription

        18.3.4. By Distribution Channel 

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Oceania Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn Analysis, By Market Taxonomy, 2016-2021

    19.3. Current and Future Market Size (US$ Mn) Analysis, By Market Taxonomy, 2022-2031

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Prescription

        19.3.4. By Distribution Channel 

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Dry Eye Syndrome Market Analysis 2016-2021 and Forecast 2022-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2016-2021

    20.3. Current and Future Market Size (US$ Mn) Analysis, By Market Taxonomy, 2022-2031

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. North Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Prescription

        20.3.4. By Distribution Channel 

    20.4. Market Attractiveness Analysis

    20.5. Drivers and Restraints - Impact Analysis

21. Countries Dry Eye Syndrome Market 2022 & 2031

    21.1. U.S. Dry Eye Syndrome Market Analysis

        21.1.1. By Product

        21.1.2. By Prescription

        21.1.3. By Distribution Channel 

    21.2. Canada Dry Eye Syndrome Market Analysis

        21.2.1. By Product

        21.2.2. By Prescription

        21.2.3. By Distribution Channel 

    21.3. Brazil Dry Eye Syndrome Market Analysis

        21.3.1. By Product

        21.3.2. By Prescription

        21.3.3. By Distribution Channel 

    21.4. Mexico Dry Eye Syndrome Market Analysis

        21.4.1. By Product

        21.4.2. By Prescription

        21.4.3. By Distribution Channel 

    21.5. U.K. Dry Eye Syndrome Market Analysis

        21.5.1. By Product

        21.5.2. By Prescription

        21.5.3. By Distribution Channel 

    21.6. Germany Dry Eye Syndrome Market Analysis

        21.6.1. By Product

        21.6.2. By Prescription

        21.6.3. By Distribution Channel 

    21.7. France Dry Eye Syndrome Market Analysis

        21.7.1. By Product

        21.7.2. By Prescription

        21.7.3. By Distribution Channel 

    21.8. Italy Dry Eye Syndrome Market Analysis

        21.8.1. By Product

        21.8.2. By Prescription

        21.8.3. By Distribution Channel 

    21.9. Spain Dry Eye Syndrome Market Analysis

        21.9.1. By Product

        21.9.2. By Prescription

        21.9.3. By Distribution Channel 

    21.10. Russia Dry Eye Syndrome Market Analysis

        21.10.1. By Product

        21.10.2. By Prescription

        21.10.3. By Distribution Channel 

    21.11. Poland Dry Eye Syndrome Market Analysis

        21.11.1. By Product

        21.11.2. By Prescription

        21.11.3. By Distribution Channel 

    21.12. Japan Dry Eye Syndrome Market Analysis

        21.12.1. By Product

        21.12.2. By Prescription

        21.12.3. By Distribution Channel 

    21.13. China Dry Eye Syndrome Market Analysis

        21.13.1. By Product

        21.13.2. By Prescription

        21.13.3. By Distribution Channel 

    21.14. South Korea Dry Eye Syndrome Market Analysis

        21.14.1. By Product

        21.14.2. By Prescription

        21.14.3. By Distribution Channel 

    21.15. India Dry Eye Syndrome Market Analysis

        21.15.1. By Product

        21.15.2. By Prescription

        21.15.3. By Distribution Channel 

    21.16. Thailand Dry Eye Syndrome Market Analysis

        21.16.1. By Product

        21.16.2. By Prescription

        21.16.3. By Distribution Channel 

    21.17. Indonesia Dry Eye Syndrome Market Analysis

        21.17.1. By Product

        21.17.2. By Prescription

        21.17.3. By Distribution Channel 

    21.18. Malaysia Dry Eye Syndrome Market Analysis

        21.18.1. By Product

        21.18.2. By Prescription

        21.18.3. By Distribution Channel 

    21.19. Vietnam Dry Eye Syndrome Market Analysis

        21.19.1. By Product

        21.19.2. By Prescription

        21.19.3. By Distribution Channel 

    21.20. Australia Dry Eye Syndrome Market Analysis

        21.20.1. By Product

        21.20.2. By Prescription

        21.20.3. By Distribution Channel 

    21.21. New Zealand Dry Eye Syndrome Market Analysis

        21.21.1. By Product

        21.21.2. By Prescription

        21.21.3. By Distribution Channel 

    21.22. GCC Countries Dry Eye Syndrome Market Analysis

        21.22.1. By Product

        21.22.2. By Prescription

        21.22.3. By Distribution Channel 

    21.23. South Africa Dry Eye Syndrome Market Analysis

        21.23.1. By Product

        21.23.2. By Prescription

        21.23.3. By Distribution Channel 

22. Market Structure Analysis

    22.1. Market Analysis, By Tier of Companies 

    22.2. Market Concentration

    22.3. Market Presence Analysis

        22.3.1. By Regional footprint of Players

        22.3.2. Product foot print by Players

        22.3.3. Channel Foot Print by Players 

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Deep Dive 

        23.2.1. Allergan Plc.

            23.2.1.1. Product Portfolio

            23.2.1.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.1.3. Sales Footprint

            23.2.1.4. Strategy Overview

                23.2.1.4.1. Marketing Strategy

                23.2.1.4.2. Product Strategy

                23.2.1.4.3. Channel Strategy

        23.2.2. Novartis AG

            23.2.2.1. Product Portfolio

            23.2.2.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.2.3. Sales Footprint

            23.2.2.4. Strategy Overview

                23.2.2.4.1. Marketing Strategy

                23.2.2.4.2. Product Strategy

                23.2.2.4.3. Channel Strategy

        23.2.3. Otsuka Pharmaceutical Co.,Ltd.

            23.2.3.1. Product Portfolio

            23.2.3.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.3.3. Sales Footprint

            23.2.3.4. Strategy Overview

                23.2.3.4.1. Marketing Strategy

                23.2.3.4.2. Product Strategy

                23.2.3.4.3. Channel Strategy

        23.2.4. Santen Pharmaceutical Co Ltd.

            23.2.4.1. Product Portfolio

            23.2.4.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.4.3. Sales Footprint

            23.2.4.4. Strategy Overview

                23.2.4.4.1. Marketing Strategy

                23.2.4.4.2. Product Strategy

                23.2.4.4.3. Channel Strategy

        23.2.5. Bausch Health Companies Inc.

            23.2.5.1. Product Portfolio

            23.2.5.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.5.3. Sales Footprint

            23.2.5.4. Strategy Overview

                23.2.5.4.1. Marketing Strategy

                23.2.5.4.2. Product Strategy

                23.2.5.4.3. Channel Strategy

        23.2.6. Akorn, Inc. 

            23.2.6.1. Product Portfolio

            23.2.6.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.6.3. Sales Footprint

            23.2.6.4. Strategy Overview

                23.2.6.4.1. Marketing Strategy

                23.2.6.4.2. Product Strategy

                23.2.6.4.3. Channel Strategy

        23.2.7. Johnson & Johnson, Inc.

            23.2.7.1. Product Portfolio

            23.2.7.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.7.3. Sales Footprint

            23.2.7.4. Strategy Overview

                23.2.7.4.1. Marketing Strategy

                23.2.7.4.2. Product Strategy

                23.2.7.4.3. Channel Strategy

        23.2.8. Thea Pharmaceuticals Limited

            23.2.8.1. Product Portfolio

            23.2.8.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.8.3. Sales Footprint

            23.2.8.4. Strategy Overview

                23.2.8.4.1. Marketing Strategy

                23.2.8.4.2. Product Strategy

                23.2.8.4.3. Channel Strategy

        23.2.9. OASIS Medical

            23.2.9.1. Product Portfolio

            23.2.9.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.9.3. Sales Footprint

            23.2.9.4. Strategy Overview

                23.2.9.4.1. Marketing Strategy

                23.2.9.4.2. Product Strategy

                23.2.9.4.3. Channel Strategy

        23.2.10. Altaire Pharmaceuticals Inc.

            23.2.10.1. Product Portfolio

            23.2.10.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.10.3. Sales Footprint

            23.2.10.4. Strategy Overview

                23.2.10.4.1. Marketing Strategy

                23.2.10.4.2. Product Strategy

                23.2.10.4.3. Channel Strategy

        23.2.11. Boiron USA 

            23.2.11.1. Product Portfolio

            23.2.11.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.11.3. Sales Footprint

            23.2.11.4. Strategy Overview

                23.2.11.4.1. Marketing Strategy

                23.2.11.4.2. Product Strategy

                23.2.11.4.3. Channel Strategy

        23.2.12. Similasan Corporation

            23.2.12.1. Product Portfolio

            23.2.12.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.12.3. Sales Footprint

            23.2.12.4. Strategy Overview

                23.2.12.4.1. Marketing Strategy

                23.2.12.4.2. Product Strategy

                23.2.12.4.3. Channel Strategy

        23.2.13. Scope Ophthalmics Ltd.

            23.2.13.1. Product Portfolio

            23.2.13.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.13.3. Sales Footprint

            23.2.13.4. Strategy Overview

                23.2.13.4.1. Marketing Strategy

                23.2.13.4.2. Product Strategy

                23.2.13.4.3. Channel Strategy

        23.2.14. Reckitt Benckiser Group PLC

            23.2.14.1. Product Portfolio

            23.2.14.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.14.3. Sales Footprint

            23.2.14.4. Strategy Overview

                23.2.14.4.1. Marketing Strategy

                23.2.14.4.2. Product Strategy

                23.2.14.4.3. Channel Strategy

        23.2.15. Medicom Healthcare Ltd 

            23.2.15.1. Product Portfolio

            23.2.15.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.15.3. Sales Footprint

            23.2.15.4. Strategy Overview

                23.2.15.4.1. Marketing Strategy

                23.2.15.4.2. Product Strategy

                23.2.15.4.3. Channel Strategy

        23.2.16. FDC Limited.

            23.2.16.1. Product Portfolio

            23.2.16.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.16.3. Sales Footprint

            23.2.16.4. Strategy Overview

                23.2.16.4.1. Marketing Strategy

                23.2.16.4.2. Product Strategy

                23.2.16.4.3. Channel Strategy

        23.2.17. Lupin Limited 

            23.2.17.1. Product Portfolio

            23.2.17.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.17.3. Sales Footprint

            23.2.17.4. Strategy Overview

                23.2.17.4.1. Marketing Strategy

                23.2.17.4.2. Product Strategy

                23.2.17.4.3. Channel Strategy

        23.2.18. Jamjoom Pharmaceuticals Co. 

            23.2.18.1. Product Portfolio

            23.2.18.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.18.3. Sales Footprint

            23.2.18.4. Strategy Overview

                23.2.18.4.1. Marketing Strategy

                23.2.18.4.2. Product Strategy

                23.2.18.4.3. Channel Strategy

        23.2.19. Sentiss Pharma Private limited 

            23.2.19.1. Product Portfolio

            23.2.19.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.19.3. Sales Footprint

            23.2.19.4. Strategy Overview

                23.2.19.4.1. Marketing Strategy

                23.2.19.4.2. Product Strategy

                23.2.19.4.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 02: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 03: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 04: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Region

Table 05: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 06: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 07: North America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 08: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 09: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 10: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 11: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 12: Latin America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 13: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 14: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 15: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 16: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 17: Europe Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 18: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 19: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 20: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 21: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 22: South Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 23: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 24: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 25: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 26: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 27: East Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 28: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 29: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 30: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 31: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 32: Oceania Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 33: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 34: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Table 35: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 36: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 37: MEA Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2016-2021 and Forecast 2022-2031, By Product

Table 38: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Prescription

Table 39: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Dry Eye Syndrome Treatment Market Volume Analysis (000’ Units), 2016-2021

Figure 02: Dry Eye Syndrome Treatment Market Volume Forecast (000’ Units), 2022-2031

Figure 03: Cyclosporine Pricing Analysis (US$) for Per Unit (Per pack of 60 0.4 ml vials), By Region, 2021

Figure 04: Topical Corticosteroids Pricing Analysis (US$) for Per Unit (Per 5ml bottle), By Region, 2021

Figure 05: Artificial Tears Pricing Analysis (US$) for Per Unit (Per pack of 15 ml), By Region, 2021

Figure 06: Removable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2021

Figure 07: Dissolvable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2021

Figure 08: Oral Omega Supplements Corticosteroids Pricing Analysis (US$) for Per Unit (Per pack of 120 capsules), By Region, 2021

Figure 09: Global Dry Eye Syndrome Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2016-2021 and Forecast, 2022-2031

Figure 10: Global Dry Eye Syndrome Treatment Market Value (US$ Mn), 2016-2021

Figure 11: Global Dry Eye Syndrome Treatment Market Absolute $ Opportunity (US$ Mn), 2021-2031

Figure 12: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2031

Figure 13: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Product, 2021-2031

Figure 14: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product, 2022-2031

Figure 15: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Prescription, 2022 & 2031

Figure 16: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Prescription, 2021-2031

Figure 17: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription, 2022-2031

Figure 18: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2031

Figure 19: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2021-2031

Figure 20: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel, 2022-2031

Figure 21: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Region, 2022 & 2031

Figure 22: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Region, 2021-2031

Figure 23: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Region, 2022-2031

Figure 24: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 25: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 26: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 27: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 28: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 29: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 30: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 31: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 32: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 33: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 34: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 35: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 36: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 37: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 38: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 39: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 40: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 41: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 42: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 43: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 44: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 45: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 46: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 47: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 48: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 49: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 50: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 51: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 52: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 53: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 54: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 55: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 56: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 57: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 58: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 59: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 60: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2016-2021

Figure 61: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 62: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product

Figure 63: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription

Figure 64: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 65: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 66: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 67: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 68: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 69: U.S. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 70: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 71: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 72: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 73: Canada Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 74: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 75: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 76: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 77: Brazil Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 78: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 79: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 80: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 81: Mexico Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 82: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 83: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 84: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 85: U.K. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 86: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 87: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 88: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 89: Germany Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 90: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 91: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 92: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 93: France Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 94: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 95: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 96: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 97: Italy Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 98: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 99: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 100: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 101: Spain Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 102: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 103: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 104: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 105: Russia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 106: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 107: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 108: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 109: Poland Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 110: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 111: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 112: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 113: Japan Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 114: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 115: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 116: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 117: China Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 118: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 119: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 120: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 121: South Korea Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 122: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 123: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 124: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 125: India Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 126: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 127: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 128: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 129: Thailand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 130: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 131: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 132: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 133: Indonesia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 134: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 135: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 136: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 137: Malaysia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 138: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 139: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 140: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 141: Vietnam Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 142: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 143: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 144: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 145: Australia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 146: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 147: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 148: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 149: New Zealand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 150: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 151: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 152: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 153: GCC Countries Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Figure 154: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2022 & 2031

Figure 155: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription, 2022 & 2031

Figure 156: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2022 & 2031

Figure 157: South Africa Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2022 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Short Sleep Syndrome Treatment Market

Published : July 2020

Healthcare

Severe Acute Respiratory Syndrome Treatment Market

Published : June 2018

Healthcare

Myelodysplastic Syndrome Treatment Market

Published : May 2018

Healthcare

Carcinoid Syndrome Diarrhea Treatment Market

Published : May 2017

Google translate

Dry Eye Syndrome Treatment Market